ScoreWhy is Hims & Hers Health, Inc. ?
1
Poor Management Efficiency with a low ROE of 6.19%
- The company has been able to generate a Return on Equity (avg) of 6.19% signifying low profitability per unit of shareholders funds
2
The company has declared Positive results for the last 13 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 258.59 MM
- NET PROFIT(Q) At USD 48.74 MM has Grown at 250.11%
- ROCE(HY) Highest at 41.88%
3
With ROE of 30.96%, it has a fair valuation with a 22.96 Price to Book Value
- Over the past year, while the stock has generated a return of 17.98%, its profits have risen by 5447.8% ; the PEG ratio of the company is 0
4
Consistent Returns over the last 3 years
- Along with generating 17.98% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Hims & Hers Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Hims & Hers Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hims & Hers Health, Inc.
17.98%
0.80
106.44%
S&P 500
13.22%
0.65
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
357.97%
EBIT Growth (5y)
165.18%
EBIT to Interest (avg)
-19.41
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.58
Sales to Capital Employed (avg)
2.52
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.57%
ROCE (avg)
10.04%
ROE (avg)
6.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
74
Industry P/E
Price to Book Value
22.96
EV to EBIT
106.34
EV to EBITDA
89.10
EV to Capital Employed
53.36
EV to Sales
6.89
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
50.18%
ROE (Latest)
30.96%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend31What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 258.59 MM
NET PROFIT(Q)
At USD 48.74 MM has Grown at 250.11%
ROCE(HY)
Highest at 41.88%
DEBTORS TURNOVER RATIO(HY)
Highest at 327.78 times
NET SALES(Q)
At USD 544.83 MM has Grown at 72.61%
PRE-TAX PROFIT(Q)
At USD 39.08 MM has Grown at 178.12%
CASH AND EQV(HY)
Highest at USD 1,467.29 MM
-4What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 5.91% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at -17.81 %
Here's what is working for Hims & Hers Health, Inc.
Net Profit
At USD 48.74 MM has Grown at 250.11%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 258.59 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 544.83 MM has Grown at 72.61%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 39.08 MM has Grown at 178.12%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Debtors Turnover Ratio
Highest at 327.78 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Cash and Eqv
Highest at USD 1,467.29 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Depreciation
Highest at USD 10.46 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Depreciation
At USD 10.46 MM has Grown at 26.45%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (USD MM)
Here's what is not working for Hims & Hers Health, Inc.
Debt-Equity Ratio
Highest at -17.81 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 5.91% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at USD 0.19 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
